|
Velos eResearch “Grid” Technology Set for Q1 2006 Release
Fremont, CA — October 11, 2005 — Velos, Inc., a
Silicon Valley healthcare software innovator, today announced plans
to release the next version of its collaborative research system
infrastructure, or “grid”, technology in Q1 of 2006. This pioneering
Velos eResearch technology was first put into production by six top
Comprehensive Cancer Centers in 2004 (see: www.veloseresearch.com/eres/jsp/news_pr9.html)
and automates the clinical trials process from source systems, such
as labs, adverse events and medical record systems, through data
submission to clinical trial sponsors.
In contrast to
conventional Electronic Data Capture or “EDC”, the technology
enables investigators and sponsors to propagate clinical trials to
research sites such that sites can execute the research using
systems already in production at the sites. This creates a host of
opportunities for reduced data entry, electronic source document
verification, and increased protocol and regulatory compliance. The
result is more efficient, reliable, and robust clinical trial
execution.
The coming release enables the community of Velos
investigators and their sponsors to securely publish case report
forms, structured protocols, and study execution workflow to current
and new Velos community members. With the release, all Velos
customers – which now include 14 U.S. medical centers with top 25
rankings (source: U.S. News and World Report Best Hospitals 2005) –
will have access to the grid and can originate secure clinical
trials, enroll current and new Velos sites, or participate in trials
led by other sites or sponsors.
In addition to facilitating
efficient clinical trial execution, researchers can use the grid to
distribute otherwise burdensome work loads. Some research
organizations have dozens, hundreds, or even thousands of clinical
trials to track, execute, and report on. For any one organization to
convert so many clinical trials from paper to an interoperable,
electronic medium is time-consuming. Using the Velos grid
technology, sites and sponsors can distribute the workload, share
best practices, and rapidly organize into secure, highly productive,
systems-enabled research networks.
The Velos technology is
intended to complement exciting government and industry initiatives
designed to foster more efficient, collaborative research. A great
example of such initiatives is the National Cancer Institutes’
cancer Biomedical Informatics Grid, or caBIGTM. Velos eResearch is
also compliant with commonly-used data exchange and terminology
standards.
About Velos
Velos, Inc., http://www.velos.com/.,is a leading
provider of next-generation healthcare software. Velos develops,
markets, and supports an integrated suite of clinical,
administrative, and financial products. Velos eResearch ,
the company’s flagship clinical trial management product line, has
been chosen by leading medical centers in academic medicine and
research. Velos’ specialty medical product line supports the
information needs of healthcare providers in cardiology,
cardiovascular surgery, dialysis, and transplantation. Velos is
privately held with headquarters in Fremont.
This press release contains forward-looking statements that are
subject to risks and uncertainties that could cause actual results
to differ materially from those set forth in the forward-looking
statements.
Additional information regarding Velos may be obtained by
contacting Madalynne Chapman (510-580-2661 / mchapman@velos.com) or visit http://www.velos.com/.
|
